Skip to content

Johnson & Johnson JNJ Debt Repayments

Debt Repayments at other companies

Abbott logo
AbbottABT
$1.42B+41.5%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$500M
Tenet Healthcare logo
Tenet HealthcareTHC
$33M+3.1%
Procter & Gamble logo
Procter & GamblePG
$1.36B
Merck & Co. logo
Merck & Co.MRK
$1.14B-54.4%
Stryker logo
StrykerSYK
$1B

Other financials

Income statement

See full
Revenue$25.3B+6.6%
Gross profit$17.3B+7.1%
Operating income$7.1B+7.4%
Net income$5.5B-0.1%
EPS (diluted)$2.27-0.9%

Balance sheet

See full
Cash & equivalents$20.4B+9.9%
Total debt$49.0B-3.4%
Total equity$85.0B+8.3%
Total assets$201.06B+4.0%

Cash flow

See full
Operating cash flow$8.6B+122%
CapEx$1.3B+26.7%
Free cash flow$7.3B+157%

Valuation

See full
Market cap$615.36B+51.2%
Enterprise value$643.97B+46.7%
P/E29.3×+11.3×
P/S6.3×+1.8×

Profitability

See full
Gross margin67.9%0.0pp
Operating margin26.5%+2.8pp
Net margin21.5%-3.5pp
FCF margin22.7%+2.2pp

Returns & leverage

See full
Return on equity25.7%-4.5pp
Debt / equity0.6×-0.1×
Current ratio1.1×+0.1×

Where this comes from

Reported directly by Johnson & Johnson in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermDebt.

The official record: Johnson & Johnson’s 10-K, filed February 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Johnson & Johnson's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Johnson & Johnson's debt repayments?
Johnson & Johnson (JNJ) reported debt repayments of $439.25M in Q4 2025.
What is the long-term trend for Johnson & Johnson's debt repayments?
Over 3 years (2021 to 2025), Johnson & Johnson's debt repayments has grown at a -0.8% compound annual growth rate (CAGR), from $1.8B to $1.76B.
What does debt repayments mean?
Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.